Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Dr Reddys Laboratories (RDY) over the last 3 years, with Q3 2025 value amounting to $238.4 million.

  • Dr Reddys Laboratories' Free Cash Flow rose 1846.88% to $238.4 million in Q3 2025 from the same period last year, while for Dec 2025 it was $489.5 million, marking a year-over-year increase of 3435.54%. This contributed to the annual value of $457.0 million for FY2025, which is 2241.09% down from last year.
  • Dr Reddys Laboratories' Free Cash Flow amounted to $238.4 million in Q3 2025, which was up 1846.88% from $251.1 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Free Cash Flow ranged from a high of $251.1 million in Q2 2025 and a low of $163.1 million during Q2 2024